Dihydroergotamine Mesylate and Papaverine Hydrochloride
Determining the interaction of Dihydroergotamine Mesylate and Papaverine Hydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: papaverine
Brand name: Para-Time SR
Synonyms: Papaverine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine Mesylate-Papaverine Hydrochloride Injection
- Dihydroergotamine Mesylate-Papaverine Injection
- Dihydroergotamine Mesylate-Papaya
- Dihydroergotamine Mesylate-Papillomavirus (9-Valent) Vaccine (Human, Recombinant)
- Dihydroergotamine Mesylate-Papillomavirus (Types 16, 18) Vaccine (Human, Recombinant)
- Dihydroergotamine Mesylate-Papillomavirus (Types 6, 11, 16, 18) Vaccine (Human, Recombinant)
- Papaverine Hydrochloride-Dihydroergotamine nasal
- Papaverine Hydrochloride-Dihydroergotamine Nasal Spray
- Papaverine Hydrochloride-Dilacor XR
- Papaverine Hydrochloride-Dilantin
- Papaverine Hydrochloride-Dilantin Infatabs
- Papaverine Hydrochloride-Dilantin injection